- Home
- CVKD vs NURO Comparison
CVKD vs NURO Comparison
Compare CVKD & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- NURO
- Stock Information
- Founded
- CVKD 2022
- NURO 1996
- Country
- CVKD United States
- NURO United States
- Employees
- CVKD N/A
- NURO N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- NURO Medical/Dental Instruments
- Sector
- CVKD Health Care
- NURO Health Care
- Exchange
- CVKD Nasdaq
- NURO Nasdaq
- Market Cap
- CVKD 17.1M
- NURO 8.2M
- IPO Year
- CVKD 2023
- NURO N/A
- Fundamental
- Price
- CVKD $15.24
- NURO $4.55
- Analyst Decision
- CVKD Strong Buy
- NURO
- Analyst Count
- CVKD 2
- NURO 0
- Target Price
- CVKD $52.50
- NURO N/A
- AVG Volume (30 Days)
- CVKD 59.6K
- NURO 15.0K
- Earning Date
- CVKD 11-08-2024
- NURO 11-01-2024
- Dividend Yield
- CVKD N/A
- NURO N/A
- EPS Growth
- CVKD N/A
- NURO N/A
- EPS
- CVKD N/A
- NURO N/A
- Revenue
- CVKD N/A
- NURO $4,383,614.00
- Revenue This Year
- CVKD N/A
- NURO N/A
- Revenue Next Year
- CVKD N/A
- NURO N/A
- P/E Ratio
- CVKD N/A
- NURO N/A
- Revenue Growth
- CVKD N/A
- NURO N/A
- 52 Week Low
- CVKD $5.40
- NURO $2.66
- 52 Week High
- CVKD $32.55
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- NURO 65.06
- Support Level
- CVKD $11.19
- NURO $3.96
- Resistance Level
- CVKD $15.93
- NURO $4.69
- Average True Range (ATR)
- CVKD 1.36
- NURO 0.22
- MACD
- CVKD 0.23
- NURO 0.04
- Stochastic Oscillator
- CVKD 61.01
- NURO 82.35
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.